Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Cross-reactivity00:42

Cross-reactivity

Overview

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bruton's tyrosine kinase inhibitors: a new class of multiple sclerosis therapeutics.

The Lancet. Neurology·2026
Same author

Neuropathic pain in multiple sclerosis: discrepancies between DN4 screening and neurophysiological measures.

Multiple sclerosis and related disorders·2026
Same author

Efficacy and safety of a bodyweight-adjusted higher dose of ocrelizumab in relapsing (MUSETTE) and primary progressive (GAVOTTE) multiple sclerosis: two multicentre, randomised, double-blind, parallel-group phase 3b trials.

Lancet (London, England)·2026
Same author

Socioeconomic impact of depression and pain in patients with neuromyelitis optica spectrum disorders.

Neurological research and practice·2026
Same author

Emerging CSF and Serum Biomarkers in Multiple Sclerosis: Cytokines, MOG, GFAP, and Beyond.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Glatiramer acetate stimulates phagocytosis and intracellular killing of <i>Escherichia coli</i> by macrophages and microglial cells.

Frontiers in immunology·2026

Related Experiment Video

Updated: May 28, 2026

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis
05:55

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Published on: December 1, 2023

Antibody response in MOG(35-55) induced EAE.

Patrice H Lalive1, Nicolas Molnarfi, Mahdia Benkhoucha

  • 1Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.

Journal of Neuroimmunology
|October 14, 2011
PubMed
Summary

In experimental autoimmune encephalomyelitis (EAE), mice developed antibodies against myelin oligodendrocyte glycoprotein (MOG) and nucleic acids. This suggests a novel role for anti-nucleic acid antibodies in central nervous system (CNS) autoimmune disease pathogenesis.

More Related Videos

Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice
08:03

Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice

Published on: April 15, 2014

Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
06:57

Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis

Published on: May 12, 2023

Related Experiment Videos

Last Updated: May 28, 2026

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis
05:55

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Published on: December 1, 2023

Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice
08:03

Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice

Published on: April 15, 2014

Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
06:57

Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis

Published on: May 12, 2023

Area of Science:

  • Neuroimmunology
  • Autoimmunity
  • Central Nervous System (CNS) research

Background:

  • Neurological deficits in multiple sclerosis and EAE are linked to T and B cell responses against CNS antigens.
  • The specific role of B cell responses beyond direct antigen recognition in EAE pathogenesis requires further elucidation.

Purpose of the Study:

  • To investigate the humoral immune response during experimental autoimmune encephalomyelitis (EAE).
  • To determine if B cells and antibodies targeting nucleic acids play a role in EAE pathogenesis.

Main Methods:

  • Induction of EAE in mice using myelin oligodendrocyte glycoprotein (MOG(35-55)) peptide.
  • Monitoring of serum antibody levels, including anti-MOG and anti-nucleic acid antibodies, during disease progression.

Main Results:

  • Mice immunized with MOG(35-55) developed significant serum levels of anti-MOG antibodies correlating with EAE progression.
  • EAE mice also developed antibodies against DNA and RNA, mirroring serological findings in systemic lupus erythematosus.

Conclusions:

  • The presence of anti-nucleic acid antibodies in EAE suggests a potential role for these antibodies in the pathogenesis of CNS autoimmunity.
  • This highlights a previously unappreciated mechanism involving anti-nucleic responsive B cells in EAE.